Emerging issues

National Academies propose initiative to sequence all RNA molecules
News

National Academies propose initiative to sequence all RNA molecules

April 19, 2024

Unlocking the epitranscriptome could transform health, medicine, agriculture, energy and national security.

When authoritative sources hold  onto bad data
News

When authoritative sources hold onto bad data

Dec. 23, 2023

A legal scholar explains the need for government databases to retract information.

Can science publishing be both open and equitable?
Feature

Can science publishing be both open and equitable?

Dec. 14, 2023

An updated memo from the White House Office of Science and Technology Policy has researchers, funders and publishers looking ahead

ASBMB weighs in on policy changes for dual-use research
Blotter

ASBMB weighs in on policy changes for dual-use research

Oct. 26, 2023

The society applauds initial steps to harmonize policies on infectious disease-related research but urges policymakers to provide clearer guidance to the scientific community.

Study: Testimonials can open acceptance to differing opinions
News

Study: Testimonials can open acceptance to differing opinions

Oct. 14, 2023

“At their core, testimonials are essentially the story of someone’s lived experience. They can be evocative or emotional,” the lead author said.

JBC editors weigh in on AI in science publishing
Journal News

JBC editors weigh in on AI in science publishing

July 24, 2023

In an editorial, they say they’ll allow its use in manuscript preparation but not during the review process.

ASBMB raises concerns about proposed NIH subaward policy
Blotter

ASBMB raises concerns about proposed NIH subaward policy

July 7, 2023

The society says the new policy, if adopted, will discourage collaboration and heighten administrative burden on scientists.

Scientists’ political donations reflect polarization in academia
Science Communication

Scientists’ political donations reflect polarization in academia

June 11, 2023

This has implications for the public’s trust in science.

Will new FDA rules help dial back expedited drugs?
Feature

Will new FDA rules help dial back expedited drugs?

May 6, 2023

Recent reforms could require companies to perform follow-up studies on drugs that received accelerated approval.